ArticleInternational journal of medical sciences2026
Integrative single-cell and bulk transcriptomic profiling identify peripheral T-cell-associated candidate biomarkers in community-acquired pneumonia.
Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Community-acquired pneumonia (CAP) is associated with marked immune dysregulation, but the peripheral T-cell transcriptional alterations linked to CAP remain incompletely defined. We aimed to characterize CAP-associated T-cell heterogeneity and identify candidate blood biomarkers by integrating single-cell and bulk transcriptomic data. Methods: GEO-processed whole-blood microarray expression data from 108 patients with CAP and 42 healthy controls (GSE65682), together with processed PBMC scRNA-seq data from five non-influenza CAP donors and four control donors (GSE164948), were analysed. Cell annotation, differential expression, disease contribution scoring, LASSO regression, and support vector machine-recursive feature elimination were used to identify candidate genes. Immune infiltration, enrichment, and pseudotime analyses were performed. Key findings were evaluated by qRT-PCR in PBMCs from an independent cohort of 36 CAP patients and 18 healthy controls. Results: T cells showed the highest disease contribution score and were enriched for pathways related to antigen processing, phosphorylation, and immune regulation. Four candidate biomarkers, CD8B, GZMM, MYL12B, and TUBA1A, showed differential expression between CAP and controls. CIBERSORT suggested increased eosinophils and monocytes and reduced resting CD4+ memory T cells in CAP. Pseudotime analysis indicated that CAP-associated T cells accumulated at higher inferred pseudotime values. qRT-PCR confirmed significant upregulation of these four candidate biomarkers in CAP PBMCs; FCGR2A also showed CAP-associated expression changes. Conclusions: Integrative transcriptomic profiling identified peripheral T-cell dysregulation in CAP and highlighted CD8B, GZMM, MYL12B, and TUBA1A as candidate blood biomarkers. These findings provide a basis for further multicenter validation and mechanistic studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.